Open1.780 | Close- |
Vol / Avg.1.935K / 22.193K | Mkt Cap26.371M |
Day Range1.780 - 1.830 | 52 Wk Range1.735 - 2.700 |
ARCA biopharma Stock (NASDAQ: ABIO) stock price, news, charts, stock research, profile.
Open1.780 | Close- |
Vol / Avg.1.935K / 22.193K | Mkt Cap26.371M |
Day Range1.780 - 1.830 | 52 Wk Range1.735 - 2.700 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2013-10-09 | Dawson James | - | Initiates Coverage On | Buy | Announces | - | 3.75 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ABIO | ARCA biopharma | -0.27% | 26.4M |
PHXM | PHAXIAM Therapeutics | 5.4% | 32.1M |
LUMO | Lumos Pharma | -2.22% | 24.4M |
NCNA | NuCana | -2.63% | 20.3M |
PRTG | Portage Biotech | 0.81% | 24.7M |
You can purchase shares of ARCA biopharma (NASDAQ: ABIO) through any online brokerage.
Other companies in ARCA biopharma’s space includes: PHAXIAM Therapeutics (NASDAQ:PHXM), Lumos Pharma (NASDAQ:LUMO), NuCana (NASDAQ:NCNA), Portage Biotech (NASDAQ:PRTG) and vTv Therapeutics (NASDAQ:VTVT).
The latest price target for ARCA biopharma (NASDAQ: ABIO) was reported by Dawson James on Wednesday, October 9, 2013. The analyst firm set a price target for 3.75 expecting ABIO to rise to within 12 months (a possible 104.92% upside). 0 analyst firms have reported ratings in the last year.
The stock price for ARCA biopharma (NASDAQ: ABIO) is $1.83 last updated Today at December 6, 2023 at 4:38 PM UTC.
There is no dividend information for ARCA biopharma.
ARCA biopharma’s Q4 earnings are confirmed for Friday, February 23, 2024.
There is no upcoming split for ARCA biopharma.
ARCA biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.